Get the latest Science News and Discoveries
Insilico Medicine doses first patient in GENESIS-IPF-3, the world’s first phase III trial of a generative AI-driven innovative drug
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert

